<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Gerbils were subjected to bilateral carotid <z:mp ids='MP_0006134'>artery occlusion</z:mp> for either 15 or 20 min </plain></SENT>
<SENT sid="1" pm="."><plain>After <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> the animals were injected i.p. with oligo-<z:chebi fb="11" ids="26333">prostaglandin</z:chebi> B (oligo-<z:chebi fb="0" ids="26335">PGB</z:chebi>; trimer of 16,16'-dimethyl-15-dehydro-<z:chebi fb="0" ids="27624">prostaglandin B1</z:chebi>) dissolved in 4% <z:chebi fb="17" ids="32139">sodium-bicarbonate</z:chebi>, or with the vehicle </plain></SENT>
<SENT sid="2" pm="."><plain>The dosing regimen of oligo-<z:chebi fb="0" ids="26335">PGB</z:chebi> was 0.5, 1, 2, 5, 10 mg/kg injected 5 min postischemia, or 1 mg/kg injected 30, 60, 90, 120 min after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, or 10 mg/kg injected 5 min and 24 h postischemia </plain></SENT>
<SENT sid="3" pm="."><plain>Behaviour of the animals and their mortality were studied for 14 days after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Administration of the drug did not affect recovery of the electrical activity in the brain and did not reduce the number of postischemic <z:hpo ids='HP_0001250'>seizures</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>Following 15 min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, administration of oligo-<z:chebi fb="0" ids="26335">PGB</z:chebi> resulted in statistically valid improvement of survival (P less than 0.04 or better) in <z:hpo ids='HP_0000001'>all</z:hpo> treatment groups </plain></SENT>
<SENT sid="6" pm="."><plain>After 20 min <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> only the double injection (10 mg/kg at 5 min and 24 h postischemia) resulted in a substantial survival improvement (64%, P less than 0.005) </plain></SENT>
<SENT sid="7" pm="."><plain>The mechanism of the drug action is unknown but, based on the available data, the authors believe it to be related to the modification of <z:chebi fb="0" ids="15843">arachidonic acid</z:chebi> metabolism in the late postischemic period </plain></SENT>
</text></document>